Abiomed Is Still in the Recovery Ward

Abiomed (NASDAQ: ABMD), a medical device maker focused on temporary heart pumps, reported its fiscal first-quarter 2020 results on Thursday.

The company is still trying to undo the damage caused in February by a confusing letter sent by the Food and Drug Administration to healthcare providers related to Abiomed's Impella RP pump.